Document is current
Any future updates will be listed below
-
Authors
Di Vincenzo, Angelo https://orcid.org/0000-0002-7678-5671
Granzotto, Marnie
Crescenzi, Marika
Fioretto, Paola
Vettor, Roberto
Rossato, Marco
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 11 April 2024
Accepted: 13 February 2025
First Online: 10 March 2025
Declarations
:
: The study was approved by the Ethics Committee of the University of Padova for the care and use of laboratory animals (CEASA protocol number 58/2018-PR, approved by the Ethics Committee of the University of Padova, Italy). All the procedures involving animal care followed institutional guidelines (European Economic Community Council Directive 86/609, OJ L 358, 1 Dec.2012, 1987; NIH Guide for the Care and Use of Laboratory Animals, NIH Publication no. 85–23, 1985).
: Not applicable.
: P.F. is involved as an advisory board member and speaker for: AstraZeneca, Eli Lilly, Boehringer Ingelheim, Novo, and Bayer. The other authors declare that they have no competing interests with this research.
